Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 152

1.

Prevalence and duration of asymptomatic Clostridium difficile carriage among healthy subjects in Pittsburgh, Pennsylvania.

Galdys AL, Nelson JS, Shutt KA, Schlackman JL, Pakstis DL, Pasculle AW, Marsh JW, Harrison LH, Curry SR.

J Clin Microbiol. 2014 Jul;52(7):2406-9. doi: 10.1128/JCM.00222-14. Epub 2014 Apr 23.

2.

Prevalence and risk factors for asymptomatic Clostridium difficile carriage.

Alasmari F, Seiler SM, Hink T, Burnham CA, Dubberke ER.

Clin Infect Dis. 2014 Jul 15;59(2):216-22. doi: 10.1093/cid/ciu258. Epub 2014 Apr 21.

3.

Risk factors for Clostridium difficile-associated diarrhea among hospitalized adults with fecal toxigenic C. difficile colonization.

Lin HJ, Hung YP, Liu HC, Lee JC, Lee CI, Wu YH, Tsai PJ, Ko WC.

J Microbiol Immunol Infect. 2015 Apr;48(2):183-9. doi: 10.1016/j.jmii.2013.08.003. Epub 2013 Sep 21.

4.

Prevalence of Clostridium difficile toxinotypes in infected patients at a tertiary care center in Lebanon.

Moukhaiber R, Araj GF, Kissoyan KA, Cheaito KA, Matar GM.

J Infect Dev Ctries. 2015 Jul 30;9(7):732-5. doi: 10.3855/jidc.6585.

5.

[Investigation of toxin genes of Clostridium difficile strains isolated from hospitalized patients with diarrhoea at Marmara University Hospital].

Deniz U, Ulger N, Aksu B, Karavuş M, Söyletir G.

Mikrobiyol Bul. 2011 Jan;45(1):1-10. Turkish.

PMID:
21341153
6.

Clostridium difficile carriage in healthy infants in the community: a potential reservoir for pathogenic strains.

Rousseau C, Poilane I, De Pontual L, Maherault AC, Le Monnier A, Collignon A.

Clin Infect Dis. 2012 Nov;55(9):1209-15. doi: 10.1093/cid/cis637. Epub 2012 Jul 25.

PMID:
22843784
7.

High prevalence of nontoxigenic Clostridium difficile isolated from hospitalized and non-hospitalized individuals in rural Ghana.

Janssen I, Cooper P, Gunka K, Rupnik M, Wetzel D, Zimmermann O, Groß U.

Int J Med Microbiol. 2016 Dec;306(8):652-656. doi: 10.1016/j.ijmm.2016.09.004. Epub 2016 Sep 24.

PMID:
27693000
8.

Use of multilocus variable number of tandem repeats analysis genotyping to determine the role of asymptomatic carriers in Clostridium difficile transmission.

Curry SR, Muto CA, Schlackman JL, Pasculle AW, Shutt KA, Marsh JW, Harrison LH.

Clin Infect Dis. 2013 Oct;57(8):1094-102. doi: 10.1093/cid/cit475. Epub 2013 Jul 23.

9.

Detection of toxigenic Clostridium difficile: comparison of the cell culture neutralization, Xpert C. difficile, Xpert C. difficile/Epi, and Illumigene C. difficile assays.

Pancholi P, Kelly C, Raczkowski M, Balada-Llasat JM.

J Clin Microbiol. 2012 Apr;50(4):1331-5. doi: 10.1128/JCM.06597-11. Epub 2012 Jan 25.

10.

Laboratory diagnosis of Clostridium difficile associated diarrhoea and molecular characterization of clinical isolates.

Russello G, Russo A, Sisto F, Scaltrito MM, Farina C.

New Microbiol. 2012 Jul;35(3):307-16. Epub 2012 Jun 30.

11.

Patients with cystic fibrosis have a high carriage rate of non-toxigenic Clostridium difficile.

Bauer MP, Farid A, Bakker M, Hoek RA, Kuijper EJ, van Dissel JT.

Clin Microbiol Infect. 2014 Jul;20(7):O446-9. doi: 10.1111/1469-0691.12439. Epub 2013 Nov 29.

12.

Clinical impact of Clostridium difficile colonization.

Hung YP, Lee JC, Lin HJ, Liu HC, Wu YH, Tsai PJ, Ko WC.

J Microbiol Immunol Infect. 2015 Jun;48(3):241-8. doi: 10.1016/j.jmii.2014.04.011. Epub 2014 Jun 2. Review.

13.

Single nucleotide polymorphisms of the tcdC gene and presence of the binary toxin gene predict recurrent episodes of Clostridium difficile infection.

Stewart DB, Berg AS, Hegarty JP.

Ann Surg. 2014 Aug;260(2):299-304. doi: 10.1097/SLA.0000000000000469.

PMID:
24374512
14.

Comparison of VIDAS CDAB and CDA immunoassay for the detection of Clostridium difficile in a tcdA- tcdB+ C. difficile prevalent area.

Shin BM, Lee EJ, Kuak EY, Yoo SJ.

Anaerobe. 2009 Dec;15(6):266-9. doi: 10.1016/j.anaerobe.2009.09.008. Epub 2009 Sep 20.

PMID:
19772927
15.

Clostridium difficile infection in an Iranian hospital.

Jalali M, Khorvash F, Warriner K, Weese JS.

BMC Res Notes. 2012 Mar 21;5:159. doi: 10.1186/1756-0500-5-159.

16.

Algorithm combining toxin immunoassay and stool culture for diagnosis of Clostridium difficile infection.

Shin BM, Kuak EY, Lee EJ, Songer JG.

J Clin Microbiol. 2009 Sep;47(9):2952-6. doi: 10.1128/JCM.00609-09. Epub 2009 Jul 22.

17.

Asymptomatic carriage of toxigenic Clostridium difficile by hospitalized patients.

Guerrero DM, Becker JC, Eckstein EC, Kundrapu S, Deshpande A, Sethi AK, Donskey CJ.

J Hosp Infect. 2013 Oct;85(2):155-8. doi: 10.1016/j.jhin.2013.07.002. Epub 2013 Aug 14.

PMID:
23954113
18.

Detection of nosocomial Clostridium difficile infections with toxigenic strains despite negative toxin A and B testing on stool samples.

Stahlmann J, Schönberg M, Herrmann M, von Müller L.

Clin Microbiol Infect. 2014 Sep;20(9):O590-2. doi: 10.1111/1469-0691.12558. Epub 2014 Feb 20.

19.

Asymptomatic carriers are a potential source for transmission of epidemic and nonepidemic Clostridium difficile strains among long-term care facility residents.

Riggs MM, Sethi AK, Zabarsky TF, Eckstein EC, Jump RL, Donskey CJ.

Clin Infect Dis. 2007 Oct 15;45(8):992-8. Epub 2007 Sep 4.

PMID:
17879913
20.

Sensitive quantification of Clostridium perfringens in human feces by quantitative real-time PCR targeting alpha-toxin and enterotoxin genes.

Nagpal R, Ogata K, Tsuji H, Matsuda K, Takahashi T, Nomoto K, Suzuki Y, Kawashima K, Nagata S, Yamashiro Y.

BMC Microbiol. 2015 Oct 19;15:219. doi: 10.1186/s12866-015-0561-y.

Supplemental Content

Support Center